Document ID: chunk:federal_register_of_legislation:F2020L01551:body:0:p9
Version: federal_register_of_legislation:F2020L01551
Segment Type: other
Provision Reference: 
Character Range: 28088–30867

entity for each exposure.

        Column 9 is derived as the total of columns 5, 6, 7 and 8, being the total exposure for the related entity.

        Column 10 is derived as the ratio of column 9 to Tier 1 Capital reported in item 6.

Item 2  Report the twenty largest exposures to related entities as as at the end of the reporting period regardless of their size in proportion to Tier 1 Capital.  Also report all exposures to related entities which exceed or are equal to 10 per cent of Tier 1 Capital, before CRM.

        In column 1, report the related entity name for each exposure to a related entity.

        In column 2, report the Legal Entity Identifier of the related entity for each exposure to a related entity. Otherwise, report N/A if the related entity has no Legal Entity Identifier.

        In column 3, report the related entity category of the related entity for each exposure.

        In column 4, report the related entity sector of the related entity for each exposure.

        In column 5, report the on-balance sheet exposures that relate to the book value of all equity investments in the related entity, before CRM. Exclude any equity investment in the related entity that has been deducted from the ADI's Level 1 (stand-alone) capital for capital adequacy purposes (refer to APS 111).

        In column 6, report the on-balance sheet exposures that do not relate to equity investments in the related entity for each exposure, before CRM.

        In column 7, report the non-market related, off-balance sheet exposures for the related entity for each exposure, before CRM.

        In column 8, report the market related, off-balance sheet exposures for the related entity for each exposure, before CRM.

        Column 9 is derived as the total of columns 5, 6, 7 and 8, being the total exposure for the related entity, before CRM.

        Column 10 is derived as the ratio of column 9 to Tier 1 Capital reported in item 6.

Section B: Extended Licensed Entity (ELE)

Item 3    Report ADI exposures to all ELE subsidiaries as at the end of the reporting period.

          In column 1, report the ELE subsidiary name for each exposure.

          In column 2, report the Legal Entity Identifier of the ELE subsidiary for each exposure. Otherwise, report N/A if the ELE subsidiary has no Legal Entity Identifier.

          In column 3, report the ELE subsidiary country of the ELE subsidiary for each exposure, using the country list.

          In column 4, report the on-balance sheet exposures that relate to the book value of all equity investments in the ELE subsidiary.

          In column 5, report the on-balance sheet exposures that do not relate to equity investments in the ELE subsidiary for each exposure.